JP2022540586A5 - - Google Patents
Info
- Publication number
- JP2022540586A5 JP2022540586A5 JP2022500799A JP2022500799A JP2022540586A5 JP 2022540586 A5 JP2022540586 A5 JP 2022540586A5 JP 2022500799 A JP2022500799 A JP 2022500799A JP 2022500799 A JP2022500799 A JP 2022500799A JP 2022540586 A5 JP2022540586 A5 JP 2022540586A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- pentyl
- biphenyl
- diol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962873692P | 2019-07-12 | 2019-07-12 | |
| US62/873,692 | 2019-07-12 | ||
| PCT/CA2020/050967 WO2021007661A1 (en) | 2019-07-12 | 2020-07-10 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540586A JP2022540586A (ja) | 2022-09-16 |
| JP2022540586A5 true JP2022540586A5 (enExample) | 2023-07-18 |
Family
ID=74209649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500799A Pending JP2022540586A (ja) | 2019-07-12 | 2020-07-10 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12195429B2 (enExample) |
| EP (1) | EP3997069A4 (enExample) |
| JP (1) | JP2022540586A (enExample) |
| WO (1) | WO2021007661A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| EP4161900A4 (en) * | 2020-06-03 | 2025-04-23 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Cannabidiolic acid (cbda) derivatives and uses thereof |
| AU2021400338A1 (en) | 2020-12-17 | 2023-07-13 | Nalu Bio, Inc. | Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1071419B1 (en) | 1998-04-21 | 2007-07-25 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Cannabinoids as antioxidants and neuroprotectants |
| CA2823724A1 (en) * | 2006-04-24 | 2007-11-08 | Allergan, Inc. | Abnormal cannabidiols as agents for lowering intraocular pressure |
| US7612101B2 (en) | 2006-04-24 | 2009-11-03 | Allergan, Inc. | Abnormal cannabidiols as agents for lowering intraocular pressure |
| WO2011006099A1 (en) * | 2009-07-10 | 2011-01-13 | Northeastern University | Angiogenic resorcinol derivatives |
| WO2012011112A1 (en) * | 2010-07-22 | 2012-01-26 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Non psychoactive cannabinoids and uses thereof |
| US9254272B2 (en) * | 2011-11-30 | 2016-02-09 | Sutter West Bay Hospitals | Resorcinol derivatives |
| WO2016138383A1 (en) * | 2015-02-27 | 2016-09-01 | The Feinstein Institute For Medical Research | Treatment method, compounds, and method of increasing trpv2 activity |
| US20210198223A1 (en) | 2017-10-20 | 2021-07-01 | Corbus Pharmaceuticals, Inc. | Methods and compositions relating to ultrapure 5-(1,1-dimethylheptyl)-resorcinol |
| CA3091088A1 (en) * | 2018-02-13 | 2019-08-22 | Beetlebung Pharma Ltd. | Cannabinoid derivatives and conjugates and uses thereof |
| WO2019234728A1 (en) | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
| US20220242844A1 (en) | 2019-07-04 | 2022-08-04 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007659A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007660A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2022551066A (ja) | 2019-10-02 | 2022-12-07 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| WO2021062557A1 (en) | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US20230122510A1 (en) | 2019-11-26 | 2023-04-20 | Canopy Growth Corporation | Cannabinoid derivatives |
| US20230059582A1 (en) | 2019-12-09 | 2023-02-23 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-07-10 WO PCT/CA2020/050967 patent/WO2021007661A1/en not_active Ceased
- 2020-07-10 JP JP2022500799A patent/JP2022540586A/ja active Pending
- 2020-07-10 US US17/626,516 patent/US12195429B2/en active Active
- 2020-07-10 EP EP20838884.3A patent/EP3997069A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023503331A5 (enExample) | ||
| JP2022540433A5 (enExample) | ||
| JP2022540432A5 (enExample) | ||
| JP2022540434A5 (enExample) | ||
| JP2022539400A5 (enExample) | ||
| JP2022551067A5 (enExample) | ||
| JP2022540585A5 (enExample) | ||
| US8673941B2 (en) | Oxazole derivatives useful as inhibitors of FAAH | |
| US8455528B2 (en) | Imidazole derivatives useful as inhibitors of FAAH | |
| JP2023503601A5 (enExample) | ||
| JP2022539401A5 (enExample) | ||
| ES2683012T3 (es) | Agente activador para el receptor activado por proliferadores de peroxisomas | |
| JP2023505513A5 (enExample) | ||
| US20110021531A1 (en) | Oxazole derivatives useful as inhibitors of faah | |
| US9073879B2 (en) | Oxazole derivatives useful as modulators of FAAH | |
| CA2741839A1 (en) | 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors | |
| US9193697B2 (en) | Oxazole derivatives useful as modulators of FAAH | |
| WO2010065760A1 (en) | Imidazo [1,2a] pyridine derivatives, their use as s1p1 agonists and methods for their production | |
| JP2011522816A (ja) | イソオキサゾール誘導体及び代謝型グルタミン酸受容体ポテンシエーターとしてのその使用 | |
| WO2017209155A1 (ja) | スルホンアミド化合物又はその塩 | |
| JP2022551066A5 (enExample) | ||
| EP1983994A2 (en) | Oxazole ketones as modulators of fatty acid amide hydrolase | |
| JP2023058571A (ja) | 軟膏剤 | |
| AU2016255424A1 (en) | Benzimidazolone and benzothiazolone compounds and their use as AMPA receptor modulators | |
| KR20100122489A (ko) | 아제티딘-유도 화합물, 그의 제조 방법 및 그의 치료학적 용도 |